Search - tctmd.com

Displaying 21 - 40 of 714

Sort: Relevancy | Date

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

DAPT De-escalation Success Varies by Sex: Meta-analysis

Yael L. Maxwell

August 21, 2025

With MISSON Act, Veterans Get More Convenient but Potentially Worse CV Care

News Daily News

With MISSION Act, Veterans Get More Convenient but Potentially Worse CV Care

Yael L. Maxwell

August 08, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Conference News SCCT 2025

Less Plaque With Intensive Medical Therapy vs Usual Care in INOCA: WARRIOR

Yael L. Maxwell

July 28, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

L.A. McKeown

June 17, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

News Daily News

Whether Angio or CT Come First in Evaluating Chest Pain, QoL After Is Similar

Yael L. Maxwell

May 20, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Conference News ACC 2025

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

Caitlin E. Cox

April 02, 2025

Advertisement

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Evolocumab Gains Expanded Indication for Primary Prevention

August 2025 Dispatch for the CV Team

DAPT De-escalation Success Varies by Sex: Meta-analysis

With MISSION Act, Veterans Get More Convenient but Potentially Worse CV Care

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Less Plaque With Intensive Medical Therapy vs Usual Care in INOCA: WARRIOR

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Whether Angio or CT Come First in Evaluating Chest Pain, QoL After Is Similar

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content